$QNT

Stepniak Michal purchased $800K of QNT

Stepniak Michal purchased 13,333 shares of Quantinuum Inc. (QNT) at $60.00 ($0.80M total) on 2026-06-05.

Original reporting
SEC EDGAR · Stepniak Michal
Published Jun 8, 2026, 8:31 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 8, 2026, 8:32 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$QNT
Bullish
medium confidence
Mentioned
$QNT
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$QNTBullishLow
01

Why it matters

The newest fact is the director’s disclosed purchase size and price ($60/share) on June 5, which may slightly improve sentiment but does not change operating outlook.

02

Market read

A single director open-market buy (~$0.8M) is a modest positive signal, but it is unlikely to drive a sustained repricing without additional fundamental catalysts.

03

What to watch

The filing notes no pre-arranged 10b5-1 plan, but it still doesn’t explain motivation or whether other insiders/large holders are changing positions.

Relevance 6/10Novelty 8/10Timing: filed June 8; purchase dated June 5

Background

The article reports a Quantinuum (QNT) Form 4 insider transaction filed with the SEC (open-market purchase by a director).

Company-level read

Ticker impact

$QNTBullishMedium confidence
Context

Director Stepniak Michal bought 13,333 shares of Quantinuum (QNT) for ~$799,980 via an open-market purchase disclosed on Form 4.

Expected impact

Likely limited near-term impact; any effect should be small and fade unless followed by additional disclosures.

Evidence & confidence

The article is a primary insider transaction with a clear buy size, but it provides no new company performance, guidance, or deal information.

Market effects

No sector read-across; this is company-specific insider ownership activity.

None indicated.

None indicated.

Counterpoint

Insider buys can be routine (compensation, diversification, or non-informational timing) and may not reflect near-term fundamentals.

Key entities

  • Quantinuum Inc.

    Subject of the SEC Form 4 insider transaction; director Stepniak Michal purchased shares.

  • Stepniak Michal

    Director who executed the open-market purchase of 13,333 QNT shares.

Related articles

$HONMed

Honeywell (NASDAQ: HON) Q2 2026 profit surges on Quantinuum gain

Honeywell (HON) amended its Q2 2026 report to correct segment backlog presentation. It said Q2 and YTD 2026 net sales rose 4% and 3%. Profit was boosted by a $6,629 million gain from Quantinuum deconsolidation, while backlog rose 12% to $38,008 million. The filing also cites margin pressure, $311 million impairments, and a $241 million debt-extinguishment loss.

$QNTMed

Why Is Quantinuum Stock Surging On Thursday? - Quantinuum (NASDAQ:QNT)

Quantinuum (NASDAQ:QNT) shares rose 6.37% to $54.67 Thursday as traders bought after the stock rebounded from its IPO floor. The company, based in Broomfield, Colorado, said it priced an upsized IPO of 28,000,000 Class A shares at $60 each, raising $1.68 billion in gross proceeds, and it cited ongoing commercialization and customer engagements across multiple sectors.